Invention Grant
US07807396B2 Insulin degrading enzyme assays for treatment of alzheimer's disease
有权
用于治疗阿尔茨海默病的胰岛素降解酶测定法
- Patent Title: Insulin degrading enzyme assays for treatment of alzheimer's disease
- Patent Title (中): 用于治疗阿尔茨海默病的胰岛素降解酶测定法
-
Application No.: US10513470Application Date: 2003-06-03
-
Publication No.: US07807396B2Publication Date: 2010-10-05
- Inventor: Louis B. Hersh
- Applicant: Louis B. Hersh
- Assignee: University of Kentucky Research Foundation
- Current Assignee: University of Kentucky Research Foundation
- Agency: McDermott Will & Emery LLP
- International Application: PCT/US03/17267 WO 20030603
- International Announcement: WO03/102016 WO 20031211
- Main IPC: G01N33/573
- IPC: G01N33/573
Abstract:
Estrogen has been shown to increase the expression and activity of amyloid peptide inactivating enzymes in the brain. Peptides have been shown to increase the activity of an amyloid peptide inactivating enzyme. Methods of identifying compounds for, and methods of treating patients with, Alzheimer's Disease is disclosed.
Public/Granted literature
- US20060087736A1 Amyloid peptide inactivating enzyme to treat alzheimer's disease Public/Granted day:2006-04-27
Information query
IPC分类:
